The tolerance property of human D3 dopamine receptor is determined by specific amino acid residues in the second cytoplasmic loop

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1773, Issue 12, 2007, Pages 1747-1758

  Westrich, Ligia ^a   Kuzhikandathil, Eldo V ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Adenylyl cyclase; Desensitization; Dyskinesia; MAP kinase; Potassium channels; Signaling

Indexed keywords

ADENYLATE CYCLASE; AMINO ACID; ARGININE; DOPAMINE 3 RECEPTOR; LYSINE; MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOPLASM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS;

ADENYLATE CYCLASE; AMINO ACID SEQUENCE; AMINO ACIDS; ANIMALS; DOPAMINE; HUMANS; MAP KINASE SIGNALING SYSTEM; MICE; MOLECULAR SEQUENCE DATA; MUTANT PROTEINS; MUTATION; PHOSPHOSERINE; PROTEIN STRUCTURE, TERTIARY; QUINPIROLE; RECEPTORS, DOPAMINE D3; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 36749012417     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2007.06.007     Document Type: Article

References (23)

1. Missale C., Nash S.R., Robinson S.W., Jaber M., and Caron M.G. Dopamine receptors: from structure to function. Physiol. Rev. 78 (1998) 189-225
2. Neve K.A., Seamans J.K., and Trantham-Davidson H. Dopamine receptor signaling. J. Recept. Signal Transduct. Res. 24 (2004) 165-205
3. Sibley D.R., and Monsma Jr. F.J. Molecular biology of dopamine receptors. Trends Pharmacol. Sci. 13 (1992) 61-69
4. Sokoloff P., Giros B., Martres M.P., Bouthenet M.L., and Schwartz J.C. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 347 (1990) 146-151
5. Robinson S.W., and Caron M.G. Selective inhibition of adenylyl cyclase type V by the dopamine D3 receptor. Mol. Pharmacol. 52 (1997) 508-514
6. Cussac D., Newman-Tancredi A., Pasteau V., and Millan M.J. Human dopamine D(3) receptors mediate mitogen-activated protein kinase activation via a phosphatidylinositol 3-kinase and an atypical protein kinase C-dependent mechanism. Mol. Pharmacol. 56 (1999) 1025-1030
7. Beom S., Cheong D., Torres G., Caron M.G., and Kim K.M. Comparative studies of molecular mechanisms of dopamine D2 and D3 receptors for the activation of extracellular signal-regulated kinase. J. Biol. Chem. 279 (2004) 28304-28314
8. Kuzhikandathil E.V., and Bartoszyk G.D. The novel antidyskinetic drug sarizotan elicits different functional responses at human D2-like dopamine receptors. Neuropharmacology 51 (2006) 873-884
9. Kuzhikandathil E.V., Yu W., and Oxford G.S. Human dopamine D3 and D2L receptors couple to inward rectifier potassium channels in mammalian cell lines. Mol. Cell. Neurosci. 12 (1998) 390-402
10. Kuzhikandathil E.V., and Oxford G.S. Dominant-negative mutants identify a role for GIRK channels in D3 dopamine receptor-mediated regulation of spontaneous secretory activity. J. Gen. Physiol. 115 (2000) 697-706
11. Kuzhikandathil E.V., Westrich L., Bakhos S., and Pasuit J. Identification and characterization of novel properties of the human D3 dopamine receptor. Mol. Cell. Neurosci. 26 (2004) 144-155
12. Werner P., Hussy N., Buell G., Jones K.A., and North R.A. D2, D3, and D4 dopamine receptors couple to G protein-regulated potassium channels in Xenopus oocytes. Mol. Pharmacol. 49 (1996) 656-661
13. Kim K.M., Nakajima Y., and Nakajima S. G protein-coupled inward rectifier modulated by dopamine agonists in cultured substantia nigra neurons. Neuroscience 69 (1995) 1145-1158
14. Gainetdinov R.R., Premont R.T., Bohn L.M., Lefkowitz R.J., and Caron M.G. Desensitization of G protein-coupled receptors and neuronal functions. Annu. Rev. Neurosci. 27 (2004) 107-144
15. Kim K.M., Valenzano K.J., Robinson S.R., Yao W.D., Barak L.S., and Caron M.G. Differential regulation of the dopamine D2 and D3 receptors by G protein-coupled receptor kinases and beta-arrestins. J. Biol. Chem. 276 (2001) 37409-37414
16. Vickery R.G., and von Zastrow M. Distinct dynamin-dependent and -independent mechanisms target structurally homologous dopamine receptors to different endocytic membranes. J. Cell Biol. 144 (1999) 31-43
17. Gainetdinov R.R., Bohn L.M., Sotnikova T.D., Cyr M., Laakso A., Macrae A.D., Torres G.E., Kim K.M., Lefkowitz R.J., Caron M.G., and Premont R.T. Dopaminergic supersensitivity in G protein-coupled receptor kinase 6-deficient mice. Neuron 38 (2003) 291-303
18. Lefkowitz R.J. G protein-coupled receptors: III. New roles for receptor kinases and beta-arrestins in receptor signaling and desensitization. J. Biol. Chem. 273 (1998) 18677-18680
19. Ferguson S.S. Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol. Rev. 53 (2001) 1-24
20. Namkung Y., and Sibley D.R. Protein kinase C mediates phosphorylation, desensitization, and trafficking of the D2 dopamine receptor. J. Biol. Chem. 279 (2004) 49533-49541
21. Costa R.M., Lin S.C., Sotnikova T.D., Cyr M., Gainetdinov R.R., Caron M.G., and Nicolelis M.A. Rapid alterations in corticostriatal ensemble coordination during acute dopamine-dependent motor dysfunction. Neuron 52 (2006) 359-369
22. Bezard E., Ferry S., Mach U., Stark H., Leriche L., Boraud T., Gross C., and Sokoloff P. Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function. Nat. Med. 9 (2003) 762-767
23. Richtand M. Behavioral sensitization, alternative splicing and D3 dopamine receptor-mediated inhibitory function. Neuropsychopharmacology 31 (2006) 2368-2375